Miglustat |
Zavesca |
Zavesca is used to treat adults with mild to moderate type I Gaucher disease. Zavesca is only used in patients who cannot be treated with enzyme replacement therapy. Zavesca has not been studied in children under 18 years of age.
Type I Gaucher disease is an inherited disease that you get from both your parents. People with Type I Gaucher disease are missing an enzyme that breaks down a chemical in the body called glucosylceramide. Too much glucosylceramide causes liver and spleen enlargement, changes in the blood, and bone disease. Zavesca may stop glucosylceramide from forming.
From the WEST scientific·clinical |
From the EAST traditional·alternative |
|
|
|
Miglustat Other1 of 1
Zavesca Consumer Information
... Zavesca is used to treat adults with mild to moderate type I Gaucher disease. Zavesca is only used in patients who cannot be treated with enzyme replacement therapy. Zavesca has not been studied in ch...
Source: U.S. Food and Drug Administration
|
|
Miglustat Articles
- Zavesca Consumer Information
... Zavesca is used to treat adults with mild to moderate type I Gaucher disease. Zavesca is only used in patients who cannot be treated with enzyme replacement therapy. Zavesca has not been studied in ch...

Not Signed In -

